EU launches €5 billion Scaleup Europe Fund to support deeptech growth

The EU has officially launched the Scaleup Europe Fund, a new investment initiative that aims to mobilise up to €5 billion for European deeptech companies, including medical innovation. The fund is intended to address a persistent problem in Europe’s innovation ecosystem: many promising companies can raise early-stage funding but struggle to access the larger rounds of capital needed to scale, commercialise, and compete globally. 

The fund is being presented as part of Europe’s broader effort to close the scale-up gap with the United States and other major innovation markets. While Europe continues to produce strong research and early-stage companies, later-stage financing often remains fragmented and slower than in competing regions. As a result, high-potential companies may move abroad, partner too early with non-European investors, or fail to grow into globally competitive firms.

According to the fund’s leadership, the new vehicle is designed to be “ultra-fast” and commercially attractive enough to bring in additional private capital. The aim is not only to provide direct financing, but to act as a catalyst for larger investment rounds and give European scaleups a stronger chance of remaining and growing in Europe.

The initiative is especially relevant for sectors such as biotech, health innovation, artificial intelligence, advanced manufacturing, and other research-intensive fields where development timelines are long and capital needs are high. 

As with other EU competitiveness initiatives, the key question will be how the fund is governed, how quickly it can deploy capital, and whether it reaches companies working in high-need but more complex areas of innovation. If implemented well, it could become part of the wider policy shift toward making Europe not only a place where scientific ideas are generated, but where they can also be developed, tested, scaled, and delivered.